
Oncology NEWS International
- Oncology NEWS International Vol 5 No 8
- Volume 5
- Issue 8
Kaiser Permanente to Evaluate Neopath's AutoPap 300 QC System
REDMOND, Wash--NeoPath Inc has signed an agreement with Kaiser Permanente to install AutoPap 300 QC Systems at its Northern California facility. Following a successful evaluation, Kaiser Permanente anticipates making the technology available to its nearly 2.5 million Northern California members.
REDMOND, Wash--NeoPath Inc has signed an agreement with KaiserPermanente to install AutoPap 300 QC Systems at its Northern Californiafacility. Following a successful evaluation, Kaiser Permanenteanticipates making the technology available to its nearly 2.5million Northern California members.
The AutoPap System rescreens Pap smear slides initially classifiedas normal, using high-speed image processing computers, videoimaging technology, and image interpretation software. In clinicaltrials in US laboratories, the system improved the detection rateof false-negative smears.
Articles in this issue
almost 30 years ago
Chemo Improves Pain Relief in Advanced Prostate Canceralmost 30 years ago
NCCR Urges Congress to Support Senate Bill for Cancer Researchalmost 30 years ago
Researchers Propose New Treatment Guidelines for HIValmost 30 years ago
Salvage Cryotherapy for Prostate Cancer Studied at M.D. Andersonalmost 30 years ago
FNA Dropped From RDOG Study Due To High Rate of Insufficient Samplesalmost 30 years ago
New Thinking on HIV Progression Leads to New Strategiesalmost 30 years ago
Hospitals Told Not to Capitate for 'Wrong' Reasonsalmost 30 years ago
More Study Needed of Possible Carcinogenesis of Winter Gas Additivealmost 30 years ago
President Makes NCAB Appointments

























































